—
C+
C+ The full Closelook — membership. Open the C+ overview

United Therapeutics Corporation (UTHR) — chart, structure and Closelook read

Home› Indices›
Pick a ticker to load its detail page.

Company snapshot — United Therapeutics Corporation

UTHR in five paragraphs: what it makes and sells, where it sits in the Closelook stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
United Therapeutics develops and sells medicines for pulmonary arterial hypertension, a disease that narrows the lung's blood vessels, through drugs such as Tyvaso DPI, Nebulized Tyvaso, Remodulin, Orenitram and Adcirca, plus the cancer drug Unituxin. It also runs an early research programme building gene-edited pig organs, including kidneys and hearts, aimed at future transplant use. The company is based in Silver Spring, Maryland, and trades in the United States.
Where it sits in the stack
United Therapeutics carries no seat in Rubin, our AI infrastructure index. In the diary's broader universe it sits in the Healthcare sector, within the Drug Manufacturers – Specialty & Generic industry.
Who it is priced against
Closelook does not carry a peer group for United Therapeutics. The market names Liquidia Corporation as a comparison, since it also sells an inhaled treprostinil therapy competing directly with Tyvaso.
Why Closelook tracks it
United Therapeutics holds a seat in the Russell 1000. The diary does not yet carry a Closelook score for it, and it has not appeared in any edition or quote so far.
What the diary watches
The diary watches whether inhaled or oral rivals erode Remodulin and Tyvaso sales, and whether the xenotransplantation research moves toward any clinical use.

United Therapeutics Corporation (UTHR) trades on US exchanges.

Written from the company’s public profile and Closelook’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Signals for this name

Every Closelook reading that exists for UTHR, from the same nightly bakes the boards use. Research diary readings, not advice.

Who it is priced against Drug Manufacturers - Specialty & Generic · United States · 5 names with week and year-to-date

Peer group

Drug Manufacturers - Specialty & Generic · United States

This name carries no Closelook score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against UTHR on the nightly bakes; the Peers tab ranks the cohort on the Closelook scores where it exists.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 55/100 · S&P 500 fund at 58, above its 50- and 200-day averagesEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-17
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 94th percentile of the window, +2.7% over 20 sessions. Factor regime → 2026-09-17
  • Sovereign pressure Index 0.00 · down 0.41 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-17

FAQ · from the current data · as of 2026-09-18

Quick answers

What is United Therapeutics Corporation (UTHR)?

United Therapeutics Corporation trades as UTHR on the US exchange (United States) in the Closelook research universe, as of the registry build of 2026-09-18.

Is UTHR in a Closelook index?

Not currently — United Therapeutics Corporation is tracked in the Closelook research universe but is not a constituent of a Closelook functional index as of 2026-09-18.

Where does UTHR trade against its moving averages?

Mixed moving-average stack: Trades -4% vs the 50-day and -5.2% vs the 200-day average, 18.4% below the 52-week high and +25% off the 52-week low; a death cross printed 6 sessions ago. Computed from daily closes. As of 2026-09-17 — a technical state from the nightly Closelook bake, not advice. The Technical tab carries the full row.

What does United Therapeutics Corporation do?

United Therapeutics develops and sells medicines for pulmonary arterial hypertension, a disease that narrows the lung's blood vessels, through drugs such as Tyvaso DPI, Nebulized Tyvaso, Remodulin, Orenitram and Adcirca, plus the cancer drug Unituxin. It also runs an early research programme building gene-edited pig organs, including kidneys and hearts, aimed at future transplant use. The company is based in Silver Spring, Maryland, and trades in the United States. Closelook does not carry a peer group for United Therapeutics. The market names Liquidia Corporation as a comparison, since it also sells an inhaled treprostinil therapy competing directly with Tyvaso.

Where does United Therapeutics Corporation sit in the AI build-out?

United Therapeutics carries no seat in Rubin, our AI infrastructure index. In the diary's broader universe it sits in the Healthcare sector, within the Drug Manufacturers – Specialty & Generic industry. United Therapeutics holds a seat in the Russell 1000. The diary does not yet carry a Closelook score for it, and it has not appeared in any edition or quote so far.

What does this page show?

A live price chart with SMA overlays and drawing tools for UTHR, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Related in the Closelook universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.